Perturbed Akt/PKB signaling has been implicated in several serious ailments, e.g., peripheral INS resistance and diabetes, Alzheimer's and Parkinson's diseases (AD, PD), and cancer [59–61]. The gene discussed is AKT1; the disease is cancer.